BTK Inhibitor Tolebrutinib in Patients With Progressive MS: Design of Phase 3 PERSEUS and HERCULES Trials

Vermersch, P; Coyle, P; Reich, D; Giovannoni, G; Oreja-Guevara, C; Arnold, D; Syed, S; Matta, A; Dukovic, D; Fox, R

EUROPEAN JOURNAL OF NEUROLOGY, 2021; 28 (): 727